Supporting The Front Line of Our Freedom January 8, 2016 • admin • Working to better protect our military personnel from chemical nerve agent attack. Related News Master License Agreement Signed with University of Maryland Baltimore for the use of galantamine as a treatment for organophosphate poisoning July 12, 2007 Countervail wins business plan competition at 8th annual Five Ventures conference. Out of 130 competing companies, Countervail wins the Biotechnology – Pharmaceutical division for best business plan presentation. April 30, 2009
